Tuesday , June 25 2019
Breaking News
Home / Tag Archives: approval

Tag Archives: approval

Cipla gets approval from USFDA for Valganciclovir Tablets

Cipla has received final approval for its Abbreviated New Drug Application (ANDA) for Valganciclovir Tablets 450mg from the United States Food and Drug Administration (USFDA). The company’s Valganciclovir Tablets 450mg is AB-rated generic therapeutic equivalent version of Roche’s Valcyte. It is a deoxynucleoside analogue cytomegalovirus (CMV) DNA polymerase inhibitor indicated ... Read More »

Tata Power receives approval to issue NCDs worth Rs 5,500 crore

Tata Power Company has received approval for issuance in one or more tranches, of noncumulative, redeemable, taxable, listed, rated securities in the form of Non-Convertible Debentures (NCDs) upto an aggregate amount not exceeding Rs 5,500 crore on private placement basis to any persons, entities, bodies corporate, companies, banks, financial institutions ... Read More »

Zydus Cadila gets final approval from USFDA for Clobazam Tablets

Zydus Cadila has received the final approval from the US Food and Drug Administration (USFDA) to market Clobazam Tablets, (US RLD-ONFI Tablet), 10 mg and 20 mg. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad. Clobazam is used in combination with other medications to treat ... Read More »

Lupin receives USFDA’s approval for generic Triamcinolone Acetonide Ointment

Lupin has received approval for its Triamcinolone Acetonide Ointment USP, 0.1% from the United States Food and Drug Administration (FDA) to market a generic version of Mylan Pharmaceuticals, Inc.’s (Mylan) Triamcinolone Acetonide Ointment, 0.1%. Lupin’s Triamcinolone Acetonide Ointment USP, 0.1% is the generic version of Mylan’s Triamcinolone Acetonide Ointment, 0.1%. ... Read More »

AMJ Land Holdings gets approval for scheme of amalgamation

AMJ Land Holdings has received an approval for scheme of amalgamation of Pudumjee Investment & Finance Company, a wholly owned subsidiary of AMJ Land Holdings, with the company. This is subject to all requisite approvals including sanction by the National Company Law Tribunal. The Board of Directors of the company ... Read More »

Strides’ arm receives USFDA’s approval for Gabapentin Capsules

Strides Pharma Science’s step‐down wholly owned subsidiary, Strides Pharma Global Pte, has received approval for Gabapentin Capsules USP, 100 mg, 300 mg, and 400 mg from the United States Food and Drug Administration (USFDA). Gabapentin Capsules is a generic version of Neurontin Capsules of Pfizer. The product received approval in ... Read More »

Zydus Cadila receives approval from USFDA for Colchicine Tablets

Zydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Colchicine Tablets USP (US RLD – ColcyrsTM), 0.6 mg. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad. This medication is used to prevent or treat attacks of gout (also ... Read More »

OCL India gets approval for scheme of Amalgamation

OCL India has received an approval from its board for implementation of the scheme of Arrangement and Amalgamation of the company and Dalmia Cement East (DCEL) & other associates into Odisha Cement (ODCL). Post-merger, ODCL shall be renamed as OCL India. The Board of Directors of the company at its ... Read More »

Reliance Capital’s arm gets R3 approval from IRDAI

Reliance Capital’s wholly owned subsidiary — Reliance Health Insurance has received R3 approval from Insurance Regulatory and Development Authority (IRDAI) for its new health insurance business. The new company will commence operations by the December quarter of 2018. Reliance Capital, a part of the Reliance Group, is one of India’s ... Read More »

Inline

Click & Download Udaipur Kiran App to read Latest News

Inline

Click & Download Udaipur Kiran App to read Latest News